C6ORF167 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.541800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.271200E-01
Normal-vs-Stage2
4.992200E-01
Normal-vs-Stage3
2.191000E-01
Normal-vs-Stage4
5.755600E-01
Stage1-vs-Stage2
9.776600E-01
Stage1-vs-Stage3
1.481040E-01
Stage1-vs-Stage4
9.826800E-01
Stage2-vs-Stage3
1.012410E-01
Stage2-vs-Stage4
9.968400E-01
Stage3-vs-Stage4
3.848400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.851400E-01
Normal-vs-AfricanAmerican
5.089600E-01
Normal-vs-Asian
1.892410E-01
Caucasian-vs-AfricanAmerican
4.156200E-01
Caucasian-vs-Asian
1.823420E-01
AfricanAmerican-vs-Asian
4.928200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.698000E-01
Normal-vs-Female
5.677200E-01
Male-vs-Female
4.263600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.899600E-01
Normal-vs-Age(41-60Yrs)
7.917800E-01
Normal-vs-Age(61-80Yrs)
2.682000E-01
Normal-vs-Age(81-100Yrs)
6.715400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.226000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.334200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.119800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.764000E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.322000E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.560800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
5.043400E-01
Normal-vs-Daily Drinker
1.434640E-01
Normal-vs-Weekly Drinker
6.271000E-01
Normal-vs-Occasional Drinker
6.805000E-01
Normal-vs-Social Drinker
7.306400E-01
Non Drinker-vs-Daily Drinker
3.286200E-01
Non Drinker-vs-Weekly Drinker
7.340400E-01
Non Drinker-vs-Occasional Drinker
6.517200E-01
Non Drinker-vs-Social Drinker
5.468800E-01
Daily Drinker-vs-Weekly Drinker
1.963380E-01
Daily Drinker-vs-Occasional Drinker
1.681210E-01
Daily Drinker-vs-Social Drinker
1.156760E-01
Weekly Drinker-vs-Occasional Drinker
9.351600E-01
Weekly Drinker-vs-Social Drinker
8.193000E-01
Occasional Drinker-vs-Social Drinker
8.818000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.072600E-01
Normal-vs-Grade 2
8.487000E-01
Normal-vs-Grade 3
9.289800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.061400E-01
Grade 1-vs-Grade 3
8.535900E-02
Grade 1-vs-Grade 4
8.072600E-01
Grade 2-vs-Grade 3
1.529350E-01
Grade 2-vs-Grade 4
8.487000E-01
Grade 3-vs-Grade 4
9.289800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.343580E-01
Normal-vs-NonDiabetic
4.599800E-01
Diabetic-vs-NonDiabetic
7.731700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.395400E-01
Normal-vs-NoPancreatitis
4.144200E-01
Pancreatitis-vs-NoPancreatitis
2.651600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.142600E-01
Normal-vs-N1
5.054600E-01
N0-vs-N1
6.249800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.932800E-01
Normal-vs-TP53-NonMutant
5.403600E-01
TP53-Mutant-vs-TP53-NonMutant
8.132400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
